Clinical Trial Update: Changing Diabetes in Children

View source ↗

Summary

A Novo Nordisk-sponsored pediatric diabetes trial (NCT02382757) has been terminated, ending the study on changing diabetes in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: TERMINATED